Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

X5 Group revenue increased by 25%

10/16/24 X5

Genetico shareholders approved the additional share issue

10/16/24 GECO

GEH obtained control over TGK-2

10/16/24 TGKB

Nefaz reported for 9 months of 2024 by RAS

10/15/24 NFAZ

Board of Directors of Avangard Bank recommended dividends

10/15/24 AVAN

Flip collected a round early

10/15/24 OTCI

Moscow Exchange launches platinum and palladium trading

10/15/24 MOEX

Kristall increased the share of LWI in sales

10/15/24 KLVZ

MGKL is updating its image

10/15/24 MGKL

Chelyabinsk Metallurgical Plant reports for 9 months of 2024 by RAS

10/14/24 CHMK